Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aarthi Shenoy, MD
Medstar Health Research Institute
Principal Investigator - Ehab Attalah, MD
Froedtert Hospital
Principal Investigator - Eric Feldman, MD
Weill Cornell Medical College - New York Presbyterian Hospital
Principal Investigator - Gary Schiller, MD
UCLA Division of Hematology/oncology, Los Angeles
Principal InvestigatorKOL profile → - Gerrit J Ossenkoppele, MD
VUMC
Principal Investigator - Hanna J Khoury, MD
Emory University Clinic
Principal Investigator - Harry Erba, MD
University of Michigan
Principal Investigator - John Storring, MD
Royal Victoria Hospital, Belfast
Principal Investigator - Joseph Jurcic, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator - Julio Hajdenberg, MD
MD Anderson Cancer centre, Orlando, FL
Principal Investigator - Karen Yee, MD
Princess Margaret Hospital, Canada
Principal Investigator - Peter Westervelt, MD
Washington University School of Medicine
Principal Investigator - Pieter Sonneveld, MD
Erasmus Medical Center
Principal Investigator - Richard Larson, MD
University of Chicago
Principal Investigator - Samir Parekh, MD
Montefiore Medical Center
Principal Investigator - Shambavi Richard, MD
Stony Brook University Medical Center
Principal Investigator - Steven Allen, MD
Monter Cancer Center
Principal Investigator - Stuart Goldberg, MD
John Theurer Cancer Center, Hackensack NJ
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Hopsital
Toronto, Ontario, Canada
- Royal Victoria Hospital
Montreal, Quebec, Canada
- Vumc
Amsterdam, Netherlands
- Erasmus Mc
Rotterdam, Netherlands
- Ucla School of Medicine
Los Angeles, California, United States
- Washington Cancer Institute
Washington D.C., District of Columbia, United States
- M.D. Anderson Cancer Center Orlando
Orlando, Florida, United States
- Emory University Clinic
Atlanta, Georgia, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- University of Michigan Health System
Ann Arbor, Michigan, United States
- Washington University, Oncology/bone Marrow Transplant
St Louis, Missouri, United States
- John Theurer Cancer Center, Hackensack University Medical Center,
Hackensack, New Jersey, United States
- Monter Cancer Center
Lake Success, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Weill Cornell Medical College - New York Presbyterian Hospital
New York, New York, United States
- Stony Brook University Medical Center
Stony Brook, New York, United States
- Montefiore Medical Center Weiler Division
The Bronx, New York, United States
- Duke Univeristy Medical Center
Durham, North Carolina, United States
- Taussig Cancer Institute
Cleveland, Ohio, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Froedtert Hospital
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2009
- Primary completion
- 31 Mar 2011
- Completion
- 31 Mar 2011
- Last update posted
- 28 Jun 2012
- Registered enrollment
- 76
- Registry id
- NCT00780598
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.